Healthcare Equipment and Supplies
Company Overview of Sanovas, Inc.
Sanovas, Inc. is a life science company that develops access, imaging, measurement, diagnostic, and therapeutic technologies and solutions for physicians and their patients around the world. Its core micro technology platforms include Via Working Channel platform for physicians that want to perform advanced diagnostic and therapeutic interventions in previously inaccessible anatomies; VasZeppelin Smart Catheter platform that enables localized execution of diagnostic and therapeutic interventions; MicroCam Imaging, a visualization and imaging technology platform; StablePath, a catheter anchoring technology that enables multi-modal interventions to be performed in a safe, predictable, and stab...
2597 Kerner Boulevard
San Rafael, CA 94901
Founded in 2009
Key Executives for Sanovas, Inc.
Co-Founder, Chairman, Chief Executive Officer and President
Vice President of Capital Markets and Development
Vice President of Clinical Affairs and Education
Vice President of Research and Development
Vice President of Product Management
Compensation as of Fiscal Year 2016.
Sanovas, Inc. Key Developments
Sanovas, Inc. Prepares for Global Expansion by Creating Innovation Center and Venture Capital Fund in China
Jun 19 17
Sanovas, Inc. announced that it has achieved an agreement with the People's Government of Suzhou, China, to establish a venture capital fund and Innovation Center at the Suzhou Institute of Nanotechnology and NanoBionics (SINANO) at the Chinese Academy of Sciences located within the Suzhou Industrial Park Biotechnology Innovation Center at BioBay, to advance the company's innovations and sales in China. Sanovas Suzhou will operate as a Wholly Foreign Owned Enterprise in China. The Sanovas Suzhou Venture Capital Fund will directly invest upwards of $75 million in the development and growth of Sanovas' groundbreaking innovations in Surgical Imaging, Thoracic Oncology, Interventional Pulmonology, E.N.T., Ophthalmology and Bioscience. The transaction creates multiple opportunities for Sanovas in China; to include the 30,000 sq. ft. Innovation Center SINANO at BioBay. The agreement provides Sanovas with access to scientific, technology and medical collaboration with SINANO faculty, scientists, engineers, doctors, and local hospitals to aide Sanovas' ongoing efforts to miniaturize and advance medical technologies and therapies to improve access (through affordability and portability) to care for global society.
Sanovas, Inc. Announces Launch of its SteriView Instrument Inspection and Infection Control System
Dec 14 16
Sanovas, Inc. announced the launch of its SteriView Instrument Inspection and Infection Control System. SteriView's technology introduces a new, front line solution in the fight against Hospital- Acquired Infections (HAI's) by enabling the direct visual inspection and cleaning of hard to reach spaces within endoscopes and medical instruments. SteriView's timing to market is being met by calls from Congress, the FDA, and the Healthcare Industry to advance the standard of care in the sterilization of medical instrumentation. The company's technology further enables Healthcare Providers the ability to maintain compliance with the new Infection Control Standards recently established by the Association for the Advancement of Medical Instrumentation (AAMI) and the American National Standards Institute (ANSI).
Sanovas, Inc. Launches Sinus Endoscopy Business to Address Global Demand for Office Based Treatments of Chronic Sinusitis
Dec 1 16
Sanovas, Inc. announced the launch of its wholly-owned subsidiary, SinuGeniX, Inc. and its RegENT™ Sinus Treatment System.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|